• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

  • Print
  • Share
  • E-mail
-

Search results from the "OB_Rx" table for query on "050794."



Active Ingredient: AZACITIDINE
Dosage Form;Route: INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Proprietary Name: VIDAZA
Applicant: CELGENE
Strength: 100MG/VIAL
Application Number: N050794
Product Number: 001
Approval Date: May 19, 2004
Reference Listed Drug Yes
RX/OTC/DISCN: RX
TE Code: AP
Patent and Exclusivity Info for this product: View

Return to Electronic Orange Book Home Page


FDA/Center for Drug Evaluation and Research
Office of Generic Drugs
Division of Labeling and Program Support
Update Frequency:

Orange Book Data - Monthly
Generic Drug Product Information & Patent Information - Daily
Orange Book Data Updated Through September 2014
Patent and Generic Drug Product Data Last Updated October 22, 2014

-
-